Crestor

Bayer sues Glenmark over its skin disorder generic

The lawsuit comes three months after Glenmark was one of several generic companies to lose a challenge against AstraZeneca, which had its patent for cholesterol drug Crestor upheld by an appeals

AZ loses Crestor patent battle in Australia

The ruling in Australia follows a victory for AZ in the defense of Crestor's IP in the US. ... Given Crestor's importance to the group … we believe this increases pressure on management to undertake some sort of M&A," said Neophytou.

Building brand strength – Part 4

When AstraZeneca's cholesterol-lowering statin, Crestor launched, Lipitor directly adapted to the market changes by evolving and repositioning its brand in Europe. ... Your Decision' campaign targeted towards healthcare professionals. This allowed

Three new members at ABPI

Shionogi is a Japan-based pharma firm that is perhaps best known for discovering the blockbuster statin Crestor (rosuvostatin).

Shionogi: an expanding commercial focus

Perhaps best known for being the company that discovered the blockbuster statin Crestor (rosuvostatin), Shionogi has largely restricted its global focus to R&D. ... Shionogi doesn't yet market its own products in Europe. Outside Japan Crestor is sold by

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]